The effect of education on quality of life in patients under interferon therapy

Hepatitis Monthly

Volumn 10, Issue 3, 2010, Pages 218-222

  Noghabi, Ahmad Ali Asadi ^a   Zandi, Mitra ^b   Mehran, Abbas ^a   Alavian, Seyed Moayed ^c   Dehkordi, Ali Hasanpour ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Education; Interferon therapy; Quality of life; Viral hepatitis

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON;

ABDOMINAL DISEASE; ADULT; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; COPING BEHAVIOR; DEMOGRAPHY; DISEASE DURATION; EDUCATION; EDUCATION PROGRAM; EMOTION; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OCCUPATION; PATIENT EDUCATION; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; VIRUS HEPATITIS; WELLBEING;

EID: 77954884746     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iran Med. 2005;8:84-90.
2. Alavian SM, Ahmadzad Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A. Hepatitis C Infection in the General Population of Iran: A Systematic Review. Hepat Mon. 2009;9(3):211-23.
3. Alavian SM. Control of Hepatitis C in Iran: Vision and Missions. Hepat Mon. 2007;7(2):57-558.
4. Alavian SM, Hajariazdeh B, Ahmadzad Asl M, Kabir A, Bagheri Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008;8(4):281-94.
5. Alavian SM. Optimal Therapy for Hepatitis C. Hepat Mon. 2004;4(2):41-2.
6. Alavian S. What to Treat with Interferon?. Hepat Mon. 2004;4(6):23-9.
7. Davis GL, Balart LA, Schiff ER, et al. Assessing healthrelated quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther. 1994;16(2):334-43.
8. Ware JE, Jr., Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology. 1999;30(2):550-5.
9. Niederau C, Bemba G, Kautz A. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany- -socioeconomic aspects in hepatitis C]. Z Gastroenterol. 2006;44(4):305-17.
10. Bagheri-Lankarani K. How to manage side effects of interferon alpha therapy in Chronic Hepatitis C?. Hepat Mon. 2004;4(6):5-8.
11. Pawlowska M, Halota W. [The adherence in the treatment of chronic hepatitis C]. Pol Merkur Lekarski. 2005;18(106):469- 72.
12. Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology. 2002;35(3):704-8.
13. Alavian SM, Foroutan H, Mirmomen S, Ghofrani H, Kabir A. Efficacy and safty of combination therapy of interferonalfa 2b plus ribavirin for chronic hepatitis C. MJIRI. 2006;19(4):291-5.
14. Kolor B. Patient education and treatment strategies implemented at a pharmacist-managed hepatitis C virus clinic. Pharmacotherapy. 2005;25(9):1230-41.
15. Zandi M, Alavian SM, Memarian R, Kazem Nejad M. Assement of the effect of self care program on quality of life in patients with cirrhosis referred to Tehran Hepatitis Center in 2003 [in Persian]. J Iran Univ Med Sci. 2004;11(41):411-22.
16. Zandi M, Adib-Hajbagheri M, Memarian R, Nejhad AK, Alavian SM. Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes. 2005;3:35.
17. Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD. Healthrelated quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan. World J Gastroenterol. 2005;11(47):7494-8.
18. Sharif F, Mohebbi S, Tabatabaee HR, Saberi-Firoozi M, Gholamzadeh S. Effects of psycho-educational intervention on health-related quality of life (QOL) of patients with chronic liver disease referring to Shiraz University of Medical Sciences. Health Qual Life Outcomes. 2005;3:81.
19. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology. 2002;36(5 Suppl 1):S237-44.